Calleja-Hernández MÁ - Search Results

1

Pharmacogenetic biomarkers of response in Crohn's disease.

Linares-Pineda TM, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ. Linares-Pineda TM, et al. Pharmacogenomics J. 2018 Jan;18(1):1-13. doi: 10.1038/tpj.2017.27. Epub 2017 Jun 20. Pharmacogenomics J. 2018. PMID: 28631723 Free article. Review.

2

Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.

Vargas-Rivas JE, Sabater-Hernández D, Calleja-Hernández MA, Faus MJ, Martínez-Martínez F. Vargas-Rivas JE, et al. Int J Clin Pharm. 2011 Oct;33(5):719-21; author reply 722-3. doi: 10.1007/s11096-011-9532-z. Epub 2011 Aug 17. Int J Clin Pharm. 2011. PMID: 21847687 No abstract available.

3

Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.

Rojo Venegas K, Aguilera Gómez M, Eisman JA, García Sánchez A, Faus Dader MJ, Calleja Hernández MA. Rojo Venegas K, et al. Pharmacogenomics. 2010 Sep;11(9):1287-303. doi: 10.2217/pgs.10.116. Pharmacogenomics. 2010. PMID: 20860468 Review.

4

Pharmacogenetics role in the safety of acenocoumarol therapy.

Jiménez-Varo E, Cañadas-Garre M, Henriques CI, Pinheiro AM, Gutiérrez-Pimentel MJ, Calleja-Hernández MÁ. Jiménez-Varo E, et al. Thromb Haemost. 2014 Sep 2;112(3):522-36. doi: 10.1160/TH13-11-0941. Epub 2014 Jun 12. Thromb Haemost. 2014. PMID: 24919870

5

Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.

Jiménez-Varo E, Cañadas-Garre M, Gutiérrez-Pimentel MJ, Calleja-Hernández MA. Jiménez-Varo E, et al. Pharmacogenet Genomics. 2014 Oct;24(10):501-13. doi: 10.1097/FPC.0000000000000082. Pharmacogenet Genomics. 2014. PMID: 25089947

6

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.

Pérez-Ramírez C, Alnatsha A, Cañadas-Garre M, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MÁ. Pérez-Ramírez C, et al. Pharmacogenet Genomics. 2017 Dec;27(12):438-444. doi: 10.1097/FPC.0000000000000307. Pharmacogenet Genomics. 2017. PMID: 28930110

7

[Effect of pharmaceutical follow-up in patients with secondary hyperparathyroidism treated with cinacalcet].

Chemello C, Aguilera M, Calleja-Hernández MA, Faus MJ. Chemello C, et al. Farm Hosp. 2012 Sep-Oct;36(5):321-7. doi: 10.1016/j.farma.2011.03.008. Epub 2011 Nov 29. Farm Hosp. 2012. PMID: 22129649 Free article. Spanish.

8

[Boceprevir and telaprevir safety in routine clinical practice].

López-Sepúlveda R, Fernández-López C, García Collado C, Jiménez Morales A, Valencia Soto C, Calleja Hernández MÁ. López-Sepúlveda R, et al. Farm Hosp. 2014 Jan 1;38(1):44-9. doi: 10.7399/FH.2014.38.1.1142. Farm Hosp. 2014. PMID: 24483859 Free article. Spanish.

9

[Improvement of the outpatient clinics after the implementation of an automated robot for delivery].

García Collado C, Madrid Paredes A, Jiménez Morales A, Calleja Hernández MÁ. García Collado C, et al. Farm Hosp. 2012 Nov-Dec;36(6):525-30. doi: 10.7399/FH.2012.36.6.45. Farm Hosp. 2012. PMID: 23461446 Free article. Spanish.

10

Pharmaceutical care in smoking cessation.

Marín Armero A, Calleja Hernandez MA, Perez-Vicente S, Martinez-Martinez F. Marín Armero A, et al. Patient Prefer Adherence. 2015 Jan 29;9:209-15. doi: 10.2147/PPA.S67707. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25678779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page